Larimar Therapeutics
LRMR
LRMR
103 hedge funds and large institutions have $483M invested in Larimar Therapeutics in 2024 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 33 increasing their positions, 23 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
49% more funds holding
Funds holding: 69 → 103 (+34)
43% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 23
9.69% more ownership
Funds ownership: 89.99% → 99.68% (+9.7%)
Holders
103
Holding in Top 10
3
Calls
$9.71M
Puts
$1.89M
Top Buyers
| 1 | +$45.9M | |
| 2 | +$32.6M | |
| 3 | +$24.9M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$10.5M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$8.26M |
Top Sellers
| 1 | -$9.94M | |
| 2 | -$3.41M | |
| 3 | -$1.25M | |
| 4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$889K |
| 5 |
Morgan Stanley
New York
|
-$494K |